Cellebrite DI (CLBT)
Software for accessing, analyzing, and managing evidence across legally sanctioned digital investigations.
Cellebrite Federal Solutions, Inc. (CFSI) répond à la norme avancée de cybersécurité du ministère américain de la Défense, renforçant ainsi son engagement en faveur de la sécurité des opérations fédérales
/PRNewswire/ -- Cellebrite (Nasdaq: CLBT), leader mondial des solutions d'investigation et de renseignement numériques basées sur l'IA pour les secteurs
Cellebrite Guardian completa la evaluación IRAP: obtiene la certificación PROTECTED
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies
Independent assessment gives Australian law enforcement, defense and national security agencies a platform for collaborating and managing digital evidence in the cloud quickly and securely TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
CFSI obtiene el Estándar Avanzado de Ciberseguridad del Departamento de Guerra de EE.UU.
/PRNewswire/ -- Cellebrite (Nasdaq: CLBT), un líder mundial en soluciones de inteligencia e investigación digital impulsadas por IA para los sectores público y
Cellebrite Federal Solutions, Inc. (CFSI) Achieves U.S. Department of War's Advanced Cybersecurity Standard, Reinforcing Commitment to Secure Federal Operations
TYSONS CORNER, Va., Sept. 1, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced its subsidiary, Cellebrite Federal Solutions, Inc. (CFSI), achieved the advanced Cybersecurity Maturity Model Certification (CMMC) Level 2 accreditation, an independent assessment conducted by a Certified Third-Party Assessment Organization (C3PAO).
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of “Moderate Buy” by Brokerages
Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 1-year price
Cellebrite stellt den Streitkräften mit der Einführung des «Portable Tactical Extraction Kit» (C-TEK) Informationen aus dem Einsatzgebiet zur Verfügung
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Cellebrite met ses capacités de renseignement sur le champ de bataille au service des forces armées avec le lancement du Portable Tactical Extraction Kit (C-TEK)
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
Cellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Bank of America Corp DE Reduces Position in Cellebrite DI Ltd. $CLBT
Bank of America Corp DE lessened its holdings in shares of Cellebrite DI Ltd. (NASDAQ: CLBT) by 11.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 619,699 shares of the company's stock after selling 80,514 shares during the quarter. Bank of America
Cellebrite Genesis for Enterprise ist ab sofort allgemein verfügbar und wird in weiteren internationalen Märkten angeboten
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT) shareholders lost money this month after the Company reported second quarter 2026 revenue of approximately
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT) shareholders lost money this month after the Company reported second quarter 2026 revenue of approximately
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)
Cellebrite DI Investigation Notice: Levi and Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) PR New
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)
Cellebrite DI Ltd. (CLBT) shareholders lost money when the stock sold off more than 30% following the Company's Q2 2026 results -- Levi & Korsinsky is investigating the Company's disclosures concerning their previous projections and related discussions.
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to an Investigation of Potential Securities Law Violations
New York, New York--(Newsfile Corp. - August 13, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript
Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd.
MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite may have made regarding its financial statements, business operations and prospects.
CLBT INVESTIGATION: Cellebrite DI Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses
Boston, Massachusetts--(Newsfile Corp. - August 13, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
Cellebrite DI Q2 Earnings Call Highlights
Cellebrite DI NASDAQ: CLBT reported second-quarter results that fell short of its expectations for annual recurring revenue, citing delayed large transactions, slower-than-anticipated pricing and expansion gains from customer migrations, and added procurement requirements for cloud and artificial intelligence offerings. The company lowered its full-year ARR and revenue outlook while raising its adjusted EBITDA target.
